<DOC>
	<DOCNO>NCT01536353</DOCNO>
	<brief_summary>The purpose study evaluate bioavailability safety AGSAV301 tablet healthy male volunteer .</brief_summary>
	<brief_title>Clinical Trial Evaluate Bioavailability Safety AGSAV301</brief_title>
	<detailed_description />
	<mesh_term>Amlodipine , Valsartan Drug Combination</mesh_term>
	<criteria>Adult males 20 40 year screen . body weight ≥ 45kg within ± 20 % ideal body weight : Ideal body weight = ( height [ cm ] 100 ) x 0.9 Be able collect blood study visit followup period Subject agree participate study give write informed consent Have history significant hepatic , renal , gastrointestinal , pulmonary , musculoskeletal , endocrine , neuropsychiatric , hematologic , cardiovascular disease Have gastrointestinal disease ( ex : Crohn 's disease , gastrointestinal ulcer ) surgery ( except Appendectomy , Hernia repair ) affect absorption medication Inappropriate Screening test ( interview , vital sigh , BP , 12lead ECG , laboratory test etc . ) Hypersensitivity reaction drug clinically significant hypersensitivity reaction history amlodipine valsartan drug abuse , history drug abuse show positive screen test urine : amphetamine , barbiturate , cocaine , opiates , benzodiazepine , cannabinoids , methadone etc . Subject take herbal medicine within 30 day , ethical drug within 14 day , OTC within 7 day begin administration investigational drug Unusual diet affect absorption , distribution , metabolism , excretion medication Subject treat investigational drug within 60 day administration investigational drug Previously donate whole blood within 60 day component blood within 30 day transfusion within 30 day Subject take inhibitor inducer drug metabolize enzyme ( Barbiturates etc . ) within 30days Subject take habitually caffeine ( caffeine &gt; 5 units/day ) Subject drunken habitually ( alcohol &gt; 21 units/week , 1 unit = pure alcohol 10ml ) unable quit drinking study smoker positive Hepatitis B , Hepatitis C , HIV Syphilis Blood Pressure range `` 140 &gt; sit SBP ≥ 90mmHg , 90 &gt; sit DBP ≥ 60mmHg '' Pulse rate range `` 95 &gt; sit Pulse Rate ≥ 45bpm ( beat per minute ) '' AST , ALT , total bilirubin twice reference range Subjects deem ineligible investigator base reason</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>